Biomarker monitoring, including fasting insulin, HOMA-IR, HbA1c, and body composition, is essential for assessing clinical response during a 12-week MOTS-c protocol
Licensed clinicians hold authority over eligibility assessment, medication selection, and prescribing outcomes after intake review
Jeffrey Egler, Nooms Chief Medical Officer, puts it, lower dose does not mean lower responsibility. In fact, because microdosing requires slower, more deliberate titration, it often demands more oversight than the standard protocol
It is important to distinguish between documented adverse effects and anecdotal patient experiences
Boolean operators (AND, OR) were deployed to formulate precise search queries
BPC-157: What the Research Says About Healing and Recovery BPC-157 has emerged as one of the most researched peptides in regenerative medicine, with over 50 published studies examining its potential for tissue repair and healing